pharmaceutical kombinationskomposition der and methods for the treatment of diabetes and metabolic disorders

摘要

The present invention provides a pharmaceutical composition for administration to a patient suffering from diabetes and other metabolic disorders, where the composition includes a) an activated, potentiated form of an antibody against human insulin receptors, and b) an activated, potentiated form of an antibody against endothelial NO synthesis.